Food and Drug Administration Simple Reauthorization Act of 2022 or the FDASRA Act of 2022
This bill reauthorizes the authority of the Food and Drug Administration to collect certain fees related to drugs, medical devices, and biosimilar biological products and modifies such fees, including the base fee amounts.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2022-07-14 | IntroReferral | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | Senate |
| 2022-07-14 | IntroReferral | Introduced in Senate | Library of Congress |